The MEG3 expression level was correlated with TNM staging, lymph node metastasis and tumor size (Supplementary Table 1) but not with age, sex, extrathyroidal extension, or multicentricity of the clinical pathological characteristics examined. This evidence concerns the gene MEG3 and metastatic malignant neoplasm in the lymph nodes.